EC Healthcare (2138) Issues Profit Warning

Bulletin Express11-24

EC Healthcare (2138) has announced that unaudited consolidated management accounts for the six months ended 30 September 2025 indicate a decrease of not more than 10% in revenue compared with approximately HK$2,062.9 million for the same period in 2024. The company also expects a drop of not more than 30% in EBITDA compared to approximately HK$247.9 million in the previous period and a decrease of not more than 90% in profit after tax relative to approximately HK$40.3 million last year.

Key factors influencing these figures include local consumption sentiment affected by an increase in outbound travel and Hong Kong residents seeking medical and wellness services in Mainland China. The absence of contributions from medical assets disposed of in the prior financial year, a less favorable service mix, and reduced operating leverage also weighed on earnings.

The company forecasts its balance sheet to remain strong, indicating that aggregate cash, time deposits, and current financial assets could total approximately HK$1,100 million as of 30 September 2025. Investors are advised to refer to the interim results announcement, expected on 28 November 2025, for full details and exercise caution when dealing in the company’s shares.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1134106693?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-24 18:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1134106693","market":"hk","top_or_hot":-1,"title":"EC Healthcare (2138) Issues Profit Warning","media":"Bulletin Express","content":"<p>EC Healthcare (2138) has announced that unaudited consolidated management accounts for the six months ended 30 September 2025 indicate a decrease of not more than 10% in revenue compared with approximately HK$2,062.9 million for the same period in 2024. The company also expects a drop of not more than 30% in EBITDA compared to approximately HK$247.9 million in the previous period and a decrease of not more than 90% in profit after tax relative to approximately HK$40.3 million last year.</p>\n<p>Key factors influencing these figures include local consumption sentiment affected by an increase in outbound travel and Hong Kong residents seeking medical and wellness services in Mainland China. The absence of contributions from medical assets disposed of in the prior financial year, a less favorable service mix, and reduced operating leverage also weighed on earnings.</p>\n<p>The company forecasts its balance sheet to remain strong, indicating that aggregate cash, time deposits, and current financial assets could total approximately HK$1,100 million as of 30 September 2025. Investors are advised to refer to the interim results announcement, expected on 28 November 2025, for full details and exercise caution when dealing in the company’s shares.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>EC Healthcare (2138) Issues Profit Warning</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEC Healthcare (2138) Issues Profit Warning\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-11-24 18:22</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>EC Healthcare (2138) has announced that unaudited consolidated management accounts for the six months ended 30 September 2025 indicate a decrease of not more than 10% in revenue compared with approximately HK$2,062.9 million for the same period in 2024. The company also expects a drop of not more than 30% in EBITDA compared to approximately HK$247.9 million in the previous period and a decrease of not more than 90% in profit after tax relative to approximately HK$40.3 million last year.</p>\n<p>Key factors influencing these figures include local consumption sentiment affected by an increase in outbound travel and Hong Kong residents seeking medical and wellness services in Mainland China. The absence of contributions from medical assets disposed of in the prior financial year, a less favorable service mix, and reduced operating leverage also weighed on earnings.</p>\n<p>The company forecasts its balance sheet to remain strong, indicating that aggregate cash, time deposits, and current financial assets could total approximately HK$1,100 million as of 30 September 2025. Investors are advised to refer to the interim results announcement, expected on 28 November 2025, for full details and exercise caution when dealing in the company’s shares.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02138","symbol_name":"医思健康","start_time":0,"source_url":"","article_id":"1134106693","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1134106693","pubTimestamp":1763979747,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"EC Healthcare (2138) has announced that unaudited consolidated management accounts for the six months ended 30 September 2025 indicate a decrease of not more than 10% in revenue compared with...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02138":"医思健康"},"translate_title":"EC Healthcare(2138)发盈警","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02138":1},"content_text":"EC Healthcare (2138) has announced that unaudited consolidated management accounts for the six months ended 30 September 2025 indicate a decrease of not more than 10% in revenue compared with approximately HK$2,062.9 million for the same period in 2024. The company also expects a drop of not more than 30% in EBITDA compared to approximately HK$247.9 million in the previous period and a decrease of not more than 90% in profit after tax relative to approximately HK$40.3 million last year.\nKey factors influencing these figures include local consumption sentiment affected by an increase in outbound travel and Hong Kong residents seeking medical and wellness services in Mainland China. The absence of contributions from medical assets disposed of in the prior financial year, a less favorable service mix, and reduced operating leverage also weighed on earnings.\nThe company forecasts its balance sheet to remain strong, indicating that aggregate cash, time deposits, and current financial assets could total approximately HK$1,100 million as of 30 September 2025. Investors are advised to refer to the interim results announcement, expected on 28 November 2025, for full details and exercise caution when dealing in the company’s shares.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"dataReport,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1134106693","isCrawlerRequest":true}